ArticleScientific reports2025
The impact of withholding and withdrawal life-sustaining treatment issues on patients with sepsis: a prospective, nationwide, multicenter cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Approximately half of the patients with sepsis require intensive care unit (ICU) management and their mortality rate remains high. The concept of withholding and withdrawal life-sustaining treatment (WWLST) issue was introduced to limit the suffering of critically ill patients. However, little is known about the characteristics and outcomes of WWLST in patients with sepsis. We conducted a nationwide cohort study of adult patients with sepsis prospectively collected from the Korean Sepsis Alliance Database of 20 tertiary referral or university-affiliated hospitals in South Korea between September 2019 and December 2021. Patients were classified according to WWLST issues and characteristics, and their prognoses were compared. Among the 11,981 patients with sepsis included in the study, 4430 (37.0%) had WWLST issues. The WWLST group was older, frailer, and had higher Sequential Organ Failure Assessment (SOFA) scores than the no-WWLST group. The WWLST group had more underlying diseases, including solid tumors (45.2% vs. 30.6%, p < 0.001) and hematologic malignancies (8.0% vs. 5.2%, p < 0.001), than the no-WWLST group. Regarding patient outcomes and interventions in the ICU, the WWLST group used vasopressors (35.4% vs. 32.8%, p = 0.003) more frequently; invasive mechanical ventilation (62.9% vs. 41.9%, p < 0.001) and continuous renal replacement therapy (40.8% vs. 17.6%, p < 0.001) were applied more frequently in the WWLST group than in the no-WWLST group. Logistic regression analysis revealed the factors associated with WWLST group to be old age, low body mass index, higher Charlson comorbidity index, clinical frailty scale, SOFA score, underlying diseases such as solid tumors and hematologic malignancies, invasive mechanical ventilation, and continuous renal replacement therapy. We predicted that the WWLST group would have a fewer ICU admissions and less invasive treatment. However, the admission rate was equivalent, and the percentage of invasive treatment, length of ICU stays, and mortality rate were higher and longer in the WWLST group. In patients with sepsis who have factors related to WWLST, appropriate communication with the patient and their family about WWLST can improve the quality of life and quality of death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.